Market Analysis
Montelukast Intermediate Market Eyeing Remarkable Growth due to Increasing Incidences of Asthma.The Montelukast Intermediate Market by Application (Asthma, Allergic Rhinitis, Bronchospasm and Urticaria) – Forecast till 2023, in accordance with the latest Market Research Future (MRFR) report.
Montelukast is a leukotriene receptor antagonist which inhibits the cysteinyl leukotriene receptor. The cysteinyl leukotriene receptor is found on smooth muscle cells, inflammatory cells, and endothelium. The endothelium is present in the respiratory mucosa both of the lower and upper airway. Montelukast is used to treat allergic rhinitis and asthma by blocking the leukotrienes (natural substances) that are likely to worsen allergies and asthma. This allows easy breathing by reducing inflammation (swelling) in the airways.
Global Montelukast Intermediate Market Is Predicted To Touch USD 4,794.763 Thousand At A 4.34% CAGR Over The Forecast Period (2015-2023).
Montelukast is indicated for chronic asthma treatment and prophylaxis in patients aged two years and above. In adults, it is used for treating asthma when the patient is symptomatic after intermittent short-acting b-agonists and will not or cannot use inhale corticosteroid. This does not work fast enough for treating asthma attacks right away, so it should not be used for treating sudden asthma attacks.
Various factors are propelling the montelukast intermediate market growth. These factors, in accordance with the MRFR report, include the worldwide prevalence of urticaria, allergic rhinitis, bronchospasm, and asthma, growing pharmaceutical industry, growing demand for montelukast from API manufacturers, rising presence of generics, and montelukast patent expiration.
Key Players
Leading players profiled in the montelukast intermediate market report include Ortin Laboratories Limited, Manus Aktteva Biopharma LLP, P.G. Shah & Co., and VIVAN Life Sciences, among others. Key players have adopted different strategies to create a niche in the market such as joint ventures, partnerships, mergers and acquisitions, product innovations, product launches, collaborations, research and development, and more.
Ask for FREE Brief Sample at: https://www.marketresearchfuture.com/sample_request/7887
On the flip side, high cost to manufacture building blocks for API and strict regulatory policies are factors that may deter the montelukast intermediate market growth over the forecast period.
Market Segmentation
The MRFR report provides a complete segmental analysis of the montelukast intermediate market report on the basis of application.
Based on application, the montelukast intermediate market is segmented into urticaria, bronchospasm, allergic rhinitis, and asthma. Of these, the asthma segment will have the largest share in the market over the forecast period.
5 Market Growth Factor Analysis
5.1 Value Chain Analysis
5.1.1 Raw Material Sourcing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 End Users
5.2 Porter’s Five Forces Model
5.2.1 Threat Of New Entrants
5.2.2 Bargaining Power Of Suppliers
5.2.3 Bargaining Power Of Buyers
5.2.4 Threat Of Substitutes
5.2.5 Intensity Of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
5.5 Clinical Trials
5.5.1 Overview
5.6 Patent Analysis
5.7 Regulatory Scenario
Browse Complete Premium Research Details and Free Sample with 78 pages Market Synopsis at:https://www.marketresearchfuture.com/reports/montelukast-intermediate-market-7887
Regional Analysis
By region, the montelukast intermediate market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will command the largest share in the market during the forecast period. This is owing to the presence of sophisticated healthcare infrastructure and giant pharmaceutical companies. The US and Canada are the key contributors in the region owing to the increasing prevalence of allergic rhinitis and asthma.
The montelukast intermediate market in Europe is predicted to have the second-largest share in the market over the forecast period. The poor air quality owing to high fuel emission is resulting in increasing incidences of chronic obstructive pulmonary disease, allergy, and asthma in France, Germany, and the UK.
The montelukast intermediate market in the APAC region is predicted to have a notable growth over the forecast period. This is on account of the increasing prevalence of respiratory diseases and the growing geriatric population.
The montelukast intermediate market in the Middle East and Africa is predicted to have a minimal share over the forecast period. The Middle East region is predicted to dominate with Saudi Arabia and Egypt being the key contributors in this region.
Ask for any Exclusive Discount Or Additional Customizations on this Report at: https://www.marketresearchfuture.com/enquiry/7887
Intended Audience
- Montelukast API Manufacturer
- Academic and Research Institutes
- Pharmaceutical Manufacturers
- Reference Laboratories
- Pharmaceutical Raw Materials Suppliers
- Montelukast Intermediate Manufacturers
- Market Research and Consulting Firms
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/montelukast-intermediate-market-7887